![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 36, 34035-34040, September 7, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
,
,
¶
From the
Max von Pettenkofer-Institut, Ludwig
Maximilians Universität, Pettenkoferstrasse 9a, 80336 München and the § Adolf-Butenandt-Institut für
Physiologische Chemie, Physikalische Biochemie und Zellbiologie,
Ludwig-Maximilians-Universität München, Schillerstrasse 42,
D-80336 München, Germany
Received for publication, January 23, 2001, and in revised form, June 1, 2001
| |
ABSTRACT |
|---|
|
|
|---|
The bacterial enteropathogen Salmonella
typhimurium employs a specialized type III secretion system to
inject toxins into host cells, which trigger signaling cascades leading
to cell death in macrophages, secretion of pro-inflammatory cytokines,
or rearrangements of the host cell cytoskeleton and thus to bacterial
invasion. Two of the injected toxins, SopE and the 69% identical
protein SopE2, are highly efficient guanine nucleotide exchange factors for the RhoGTPase Cdc42 of the host cell. However, it has been a puzzle
why S. typhimurium might employ two toxins with redundant function. We hypothesized that SopE and SopE2 might have different specificities for certain host cellular RhoGTPases. In
vitro guanine nucleotide exchange assays and surface plasmon
resonance measurements revealed that SopE is an efficient guanine
nucleotide exchange factor for Cdc42 and Rac1, whereas
SopE2 was interacting efficiently only with Cdc42, but not
with Rac1. Affinity precipitation of Cdc42·GTP and Rac1·GTP from
lysates and characteristic cytoskeletal rearrangements of infected
tissue culture cells confirmed that SopE is highly efficient at
activating Cdc42 and Rac1 in vivo, whereas
SopE2 was efficiently activating Cdc42, but not Rac1. We
conclude that the translocated effector proteins SopE and SopE2 allow
S. typhimurium to specifically activate different sets of RhoGTPase signaling cascades.
The RhoGTPase subfamily of the Ras superfamily of
small GTP-binding proteins comprises more than 10 different proteins
(1). They act as molecular switches and cycle between GDP-bound
(inactive) and GTP-bound (active) conformations (2). Activation and
inactivation of RhoGTPases is controlled by guanine nucleotide exchange
factors (GEFs),1
GTPase-activating enzymes, and guanine dissociation inhibitors (3, 4).
The eukaryotic GEFs for Rho-GTPases share two common sequence motives,
the DH (Dbl homology) and the PH (pleckstrin homology) domains, which
are responsible for targeting, binding the RhoGTPases, and catalysis of
RhoGTPase·GDP Invasion of the Gram-negative bacterial enteropathogen Salmonella
typhimurium (Salmonella enterica subspecies I serovar
Typhimurium) into non-phagocytic mammalian cells is studied as a model
system for the "trigger mechanism" of bacterial invasion (12). For triggering invasion, S. typhimurium employs the specialized
type III secretion system encoded in "Salmonella
pathogenicity island I" (SPI1) to inject/translocate a set of at
least nine different bacterial toxins (called "effector proteins")
into host cells (13-22). Inside the host cell, the effector proteins
activate signaling cascades leading to a variety of responses including
cytoskeletal rearrangements and bacterial internalization/invasion
(12).
It has been shown that Cdc42 is a key element in the
Salmonella-induced signaling cascades leading to
transcriptional activation and bacterial invasion: disruption of Cdc42
signaling by transfection with dominant negative Cdc42N17
alleles interferes with bacterial invasion and activation of c-Jun
kinase and p21-activated kinase (PAK) signaling (23-25). Rac1 plays a
less prominent role, and disruption of Rac1 signaling merely leads to
reduced S. typhimurium invasion rates, whereas inhibition of
RhoA signaling does not affect invasion at all (23). This suggests that
the translocated effector proteins of S. typhimurium may
preferentially address certain RhoGTPase signaling pathways.
Recent work has demonstrated that S. typhimurium (strain
SL1344) relies mainly on a set of three translocated effector proteins to trigger invasion. A triple mutant S. typhimurium strain
lacking SopB, SopE, and SopE2 is non-invasive, even though the SPI1
type III secretion system is still fully functional (22, 24, 26-30). SopB has phosphatidyl inositol phosphatase activity and a
sopB SopE and SopE2 of S. typhimurium are 69% identical (21, 22,
27). Besides the lack of any recognizable sequence similarity to
proteins with DH or PH domains, both proteins are highly efficient GEFs
for Cdc42 in vitro (22, 24, 32). In fact, the catalytic parameters of SopE-mediated guanine nucleotide exchange of Cdc42 are
similar to those reported for the active domains of eukaryotic GEFs for
members of the Ras superfamily (32). The specificity of SopE and SopE2
for other GTPases of the Rho subfamily has not been studied in detail.
If both bacterial virulence factors had different preferences for
different RhoGTPases, SopE and SopE2 might provide S. typhimurium with a means to differentially activate specific
signaling pathways inside the host cell.
In the present study we have analyzed the specificity of SopE and SopE2
for the RhoGTPases Cdc42 and Rac1. Biochemical analyses of purified
recombinant proteins and analysis of RhoGTPase activity in infected
tissue culture cells revealed that SopE is an efficient activator for
both Cdc42 and Rac1 in vitro and in vivo. In
contrast, SopE2 efficiently activates Cdc42, but not Rac1. This
demonstrates for the first time that expression of two homologous
translocated effectors with GEF activity for RhoGTPases allows S. typhimurium to differentially activate specific signaling pathways
within host cells.
Bacterial Strains--
All S. typhimurium strains
used in this study have been described (26) and are isogenic
derivatives of the virulent wild-type strain SL1344 (33). M516 (SL1344,
Preparation of Recombinant Proteins--
Preparation of
recombinant proteins was performed essentially as described (32, 34).
Briefly, all proteins used in this study were overexpressed as GST
fusion proteins, recovered from bacterial extracts by binding to
glutathione-Sepharose 4B (Amersham Pharmacia Biotech) and either eluted
with 20 mM glutathione (GST, GST-SopE78-240,
GST-SopE269-240, GST-Cdc42Hs1-192, and
GST-Rac11-191) or cleaved off the column by digestion with
thrombin protease (SopE78-240 and
SopE269-240, Cdc42Hs1-192 and Ha-Ras) or with
factor Xa (Rac11-191). Proteins were concentrated by
ultrafiltration (Mr cut-off 8000), snap-frozen
in liquid nitrogen, and stored at
Due to design of the expression vectors, the proteins carry the
following additional amino acids. GST-SopE78-240 carries PGISGGGGGILEFEM between the thrombin cleavage site and Leu-78 of SopE;
GST-SopE269-240 carries PGISGGGGGIL between the thrombin
cleavage site and Gly-69 of SopE2; SopE78-240 carries the
additional N-terminal amino acids GSPGISGGGGGILEFEM;
SopE269-240 carries the additional N-terminal amino
acids GSPGISGGGGGIL; GST- Rac11-191 carries GIDPGAT
between the factor Xa recognition site and Met-1 of Rac1;
Rac11-191 carries the N-terminal amino acids GIDPGAT;
Ha-Ras carries the additional N-terminal amino acids GS;
GST-Cdc42Hs1-192 carries RRASVGSKIISA between the thrombin
recognition site and Met-1 of Cdc42. Cdc42Hs1-192 carries
the N-terminal amino acids GSRRASVGSKIISA.
The expression vector for the GST fusion protein with the Rac1 and
Cdc42 binding region (aa 56-272) of human PAK1B was generously provided by E. Sander and J. G. Collard (35), and purification of
the protein bound to glutathione-Sepharose beads was performed as
described (35).
Preparation of mGDP·Cdc42Hs1-192 Complex--
To
remove the associated GDP, GST-Cdc42Hs1-192 bound to a
glutathione-Sepharose 4B column was washed with 10 ml of buffer D (50 mM Tris-HCl, pH 7.6, 100 mM NaCl, 2 mM EDTA, 2 mM DTT). Afterward, beads were
incubated as a batch in the presence of a 2.5-fold molar excess of
fluorescent mGDP (Molecular Probes, Netherlands) for 10 min at 22 °C
in buffer D. After addition of excess MgCl2,
mGDP·Cdc42Hs1-192 was cleaved off the column material
using thrombin (Amersham Pharmacia Biotech) in buffer A (4 °C;
overnight) and unbound mGDP was removed by gel filtration chromatography. Fractions containing the
mGDP·Cdc42Hs1-192 complex were identified by
fluorescence spectroscopy, pooled, concentrated by ultrafiltration
(Millipore Ultrafree-15, Mr cut-off 8000),
snap-frozen, and stored at Preparation of mGDP·Rac11-191 Complex--
For
preparation of mGDP·Rac11-191, we devised a new method
based on the high stability of the SopE·Rac1 complex (32). 2 mg of
GST-SopE78-240 was bound to a glutathione-Sepharose 4B
column. Rac11-191 (in buffer A: 50 mM
Tris-HCl, pH 7.6, 100 mM NaCl, 5 mM
MgCl2, 2 mM DTT) was applied to the column, and
unbound Rac11-191 was removed by washing with 10 ml of
buffer A. The bound Rac11-191 was eluted as
mGDP·Rac11-191 complex using buffer A (20 °C)
supplemented with 200 µM mGDP and purified and
concentrated as described above for
mGDP·Cdc42Hs1-192.
Filter Binding Assays--
Filter binding assays were performed
in buffer B (50 mM Tris-HCl, pH 7.6, 50 mM
NaCl, 5 mM MgCl2, 5 mM DTT) as
described (22, 32).
Surface Plasmon Resonance--
Association and dissociation
reactions involving GST-Cdc42Hs1-192,
GST-Rac11-191, SopE78-240, and
SopE269-240 were analyzed in buffer E (10 mM HEPES/NaOH, pH 7.3, 150 mM NaCl, 5 mM MgCl2, 0.005% Igepal CA-630 (Sigma)) using
surface plasmon resonance (BIAcore 2000 system) as described recently
(32).
Fluorescence Spectrometry--
Fluorescence measurements were
performed at 20 °C in buffer F (40 mM HEPES/NaOH, pH
7.3, 100 mM NaCl, 5 mM MgCl2) on an
Aminco Bowman series 2 fluorescence spectrometer (excitation: 366 nm; emission: 440 nm). Increasing concentrations of either
mGDP·Rac11-191 or mGDP·Cdc42Hs1-192 were
premixed with SopE78-240 or SopE269-240
(final concentrations: 25 nM). Reactions were started by
addition of unlabeled GDP (1 mM final concentration), and
dissociation of mGDP was recorded as decreased fluorescence at 440 nm.
GST-PAK-Cdc42/Rac Interactive Binding Domain Affinity
Purification Assay--
To measure the amounts of Cdc42·GTP
and Rac1·GTP in infected tissue culture cells, we performed affinity
purification assays as described (35). Briefly, confluent COS7 cells
grown in Dulbecco's modified Eagle's medium (5% fetal bovine serum)
were infected with S. typhimurium at a multiplicity of
infection of 50 bacteria/cell. Cells were washed with cold PBS and
lysed in 1 ml of GST-fish buffer (10% glycerol, 50 mM
Tris-HCl, pH 7.6, 100 mM NaCl, 1% Igepal CA-630, 2 mM MgCl2 supplemented with "complete"
protease inhibitor mixture (Roche Molecular Biochemicals)), lysates
were cleared by centrifugation (4000 × g; 4 °C),
and the activated Rac1/Cdc42 was recovered by binding to immobilized
GST-PAK-cdc42/Rac interactive binding domain fusion protein (see above;
30 min, 4 °C). The beads were washed, and the amount of activated
Cdc42·GTP and Rac1·GTP was determined by Western blot analysis
using mouse- Actin Cytoskeletal Rearrangements in Human Umbilical Vein
Endothelial Cell (HUVEC) Tissue Culture--
HUVECs were grown to
confluence in endothelial cell growth medium (Promo Cell, endothelial
cell growth supplement/H, 10% FCS) on gelatin-coated plastic
coverslips (Thermanox, Nalge Nunc International) as described
previously (37). The culture medium was replaced with serum-free
endothelial cell growth medium, and cells were infected with S. typhimurium (multiplicity of infection = 50) for 40 min,
washed, fixed with PBS and 4% paraformaldehyde, permeabilized with PBS
and 0.1% Triton X-100, and stained with rhodamine-phalloidin (Molecular Probes, 1:20 in PBS, 3% BSA). Bacteria were stained with
SopE and SopE2 Display Differential Specificities for Cdc42Hs and
Rac1--
Previous work had shown that SopE and SopE2 are efficient
guanine nucleotide exchange factors for Cdc42 (22, 32). Guanine nucleotide exchange factor activity for other RhoGTPases has not been studied in detail. Here, we have compared the GEF-activity of
SopE78-240 and SopE269-240 on
Rac11-191 and Cdc42Hs1-192.
Cdc42Hs1-192, Rac11-191, or Ha-Ras was loaded
with [3H]GDP, and we determined the rates of
SopE78-240- or SopE269-240-mediated [3H]GDP release using filter binding assays (Fig.
1; see "Materials and Methods"). In
line with earlier results (22), 1 µM
SopE78-240 and SopE269-240 catalyzed fast
[3H]GDP release from Cdc42Hs1-192 (Fig. 1,
a ( Association/Dissociation Kinetics of the Complexes between SopE,
SopE2, Rac1, and Cdc42Hs--
To analyze the binding specificity of
SopE and SopE2, we have measured the kinetics of formation and
dissociation of the complexes between Cdc42 (or Rac1) and SopE2 (or
SopE) using surface plasmon resonance. This technique allows one to
study binding/dissociation kinetics by measuring the change in mass on
the surface of a sensor chip.
GST-Cdc42Hs1-192 or GST-Rac11-191 fusion
protein (or GST as a control) was bound to a sensor chip, and we
measured the kinetics of binding of SopE78-240 (or
SopE269-240; 100 nM; Fig.
2a). The observed rates of
complex formation between GST-Cdc42Hs1-192,
GST-Rac11-191, SopE78-240, and
SopE269-240 were dependent on the concentration of the RhoGTPase applied (Fig. 2b; data not shown). From the
binding curves, we calculated the kinetic constants for complex
formation (ka) assuming simple one-step
bimolecular association reactions:SopE78-240 binds with
similar kinetics to GST-Cdc42Hs1-192 and to
GST-Rac11-191 (Table I). In
contrast, the association rate constant for formation of the
GST-Cdc42Hs1-192·SopE269-240 complex is
7-fold higher than for the
GST-Rac11-191·SopE269-240 complex.
We have also analyzed the dissociation of the complexes (Table I).
However, in the absence of GDP, dissociation was slow and the
dissociation rate constants are prone to experimental error and should
be regarded as rough estimates. The
GST-Cdc42Hs1-192·SopE78-240 complex
and the GSTRac11-191·SopE78-240
complex are roughly equally stable. In contrast, dissociation of the
GST-Rac11-191·SopE269-240 complex is 6-fold
faster than dissociation of the
GST-Cdc42Hs1-192·SopE269-240 complex
(Table I). Overall, SopE78-240 binds with very similar
equilibrium binding constants (KD = koff/ka) to
GST-Cdc42Hs1-192 and to GST-Rac11-191
(KD = 3.1 × 10
In line with previous results for the
GST-SopE78-240·Cdc42 Multiple Turnover Kinetics of SopE- and SopE2-mediated Nucleotide
Exchange--
We have also analyzed the SopE78-240- and
SopE269-240-mediated nucleotide exchange in multiple
turnover kinetic experiments using
O-(N-methylanthraniloyl-GDP (mGDP), a fluorescent GDP derivative. The fluorescence of mGDP bound to Cdc42 is 4-fold higher than the fluorescence of unbound mGDP (32, 38, 39). The kinetics
and concentration dependence of mGDP dissociation from
Cdc42Hs1-192·mGDP or Rac11-191·mGDP was
followed by fluorescence spectrometry (Fig.
3). In the
SopE78-240-mediated nucleotide exchange reactions,
Cdc42Hs1-192·mGDP nucleotide dissociation rate constants
(v) reached a plateau at 20-40 µM and the
Michaelis-Menten parameters (kcat = 5 ± 1 s
Neither with SopE78-240 nor with SopE269-240
did the observed nucleotide dissociation rate constants
(v) of Rac11-191·mGDP reach a
plateau at concentrations up to 50 µM
Rac11-191·mGDP; Fig. 3, a and b).
Therefore, we could only estimate the catalytic efficiency of
SopE78-240 and SopE269-240 from the slopes of
the linear plots shown in Fig. 3 (Table II). This indicates that the
catalytic efficiency of SopE269-240
(kobs/[Rac11-191·mGDP]) is
about 6-fold lower than the catalytic efficiency of
SopE78-240.
Affinity Precipitation Assays to Determine Substrate Specificities
of SopE and SopE2 in Vivo--
The biochemical analyses presented
above show that SopE is an efficient GEF for Rac1 and Cdc42 whereas
SopE2 is an efficient GEF for Cdc42 but not for Rac1. It was of
interest to also analyze this specificity in vivo. The
levels of GTP-bound Rac1 and Cdc42 in tissue culture cells can be
analyzed directly in an affinity precipitation assay (35, 40). This
assay is based on the ability of the Cdc42/Rac1-binding domain (CD; aa
56-272) of PAK-1 to specifically bind to activated Cdc42·GTP and
Rac1·GTP, but not to inactive Cdc42·GDP or Rac1·GDP (35).
For the analysis of RhoGTPase activation by SopE and SopE2 during the
course of an infection, we have employed the S. typhimurium SL1344 mutant M516 (sopE::aphT;
sopE2::pM218; SopE and SopE2 Have Different Effects on the Actin Cytoskeleton of
HUVECs--
In mammalian cells specific activation of Rho, Rac, and
Cdc42 leads to characteristic rearrangements of the actin cytoskeleton. Usually, activation of Cdc42 is associated with the formation of
filopodia and activation of Rac1 with formation of lamellipodia ("ruffles"; Refs. 9-11). Therefore, the differential signaling capacity of SopE and SopE2 might lead to different cytoskeletal rearrangements in infected tissue culture cells. In HUVECs, activation of Cdc42 and Rac1 induces formation of filopodia and lamellipodia, respectively (37, 41). Therefore, we have infected HUVECs for 40 min
with S. typhimurium strain M516 or with M516 complemented with pM136 (SopE1-240-M45) or with pM226
(SopE21-240-M45). M516 did not induce actin cytoskeletal
rearrangements (Fig. 5a). In
contrast, M516 complemented with pM136 (SopE1-240-M45) induced the formation of lamellipodia. Infection with M516 complemented with pM226 (SopE21-240-M45) induced formation of
filopodia, whereas only a minority of infected cells formed
lamellipodia (Fig. 5, a and b). The small number
of cells forming lamellipodia (Fig. 5b; M516 + pM226) might
be attributable to indirect activation of Rac1 by activated Cdc42 (11).
In conclusion, these data are in line with our observation that SopE
can efficiently activate Rac1 (and Cdc42) signaling, whereas SopE2
activates Cdc42 but not Rac1 in vivo.
It is well established that the translocated S. typhimurium protein SopE acts as an efficient GEF for host
cellular Rho-GTPases both in vitro and in vivo
(24, 32). This was of special interest, since SopE does not share any
recognizable sequence similarity to eukaryotic GEFs or any other known
proteins. Recently, it was discovered that S. typhimurium
translocates an additional, 69% identical effector protein named SopE2
into host cells (21, 22). SopE2 is also capable of activating
Rho-GTPase signaling cascades leading to cytoskeletal rearrangements
and bacterial entry (22). Why does S. typhimurium
translocate two structurally and functionally similar effector proteins
into host cells? We hypothesized that differences in the specificity of
SopE and SopE2 for certain RhoGTPases might be one possible
explanation. As activation of different RhoGTPases leads to specific
changes in key cellular functions (i.e. actin cytoskeletal
rearrangements, activation of transcription factors; Ref. 4), this
might enable S. typhimurium to precisely manipulate host
cell physiology. Therefore, we have analyzed in the present study the
specificity of SopE and SopE2 for Cdc42 and Rac1. Indeed, we found SopE
is a potent GEF for Cdc42 and for Rac1 both in vitro and
in vivo, whereas SopE2 is much more active on Cdc42 than on
Rac1. 1) In the absence of free guanine nucleotide, the equilibrium
binding of SopE2 to Cdc42 is ~40-fold stronger than binding of SopE2
to Rac1. 2) SopE2-mediated in vitro guanine nucleotide
exchange is ~10-fold more efficient for Cdc42 than for Rac1. 3)
Affinity precipitation assays revealed that, upon translocation into
COS7 tissue culture cells, SopE2 activates Cdc42, but essentially no
Rac1. 4) Translocation of SopE2 into HUVEC tissue culture cells induces
actin cytoskeletal rearrangements characteristic for specific
activation of Cdc42. In contrast, SopE interacted efficiently with both
Cdc42 and Rac1 in vitro and in vivo. Analysis of
a SopE-SopE2 chimeric protein (promoter region and aa 1-95 of SopE (=
translocation signal) fused to aa 96-240 of SopE2 (= catalytic
domain)) verified that the observed specificities in vivo
are really attributable to the catalytic C-terminal domains (data not
shown). Altogether, SopE and SopE2 provide S. typhimurium
with a means to specifically activate either Cdc42 and Rac1
or Cdc42 but not Rac1.
Eukaryotic GEFs share a common functional unit (DH plus PH domain),
which facilitates GTPase binding and catalysis. Yet, the eukaryotic
GEFs for RhoGTPases display different specificities for different
subsets of RhoGTPases (5, 42). The three-dimensional structure of Rac1
complexed with the DH and PH domains of the eukaryotic GEF Tiam1 has
identified the amino acid residues determining the binding specificity
(43). Unfortunately, as SopE and SopE2 do not share any recognizable
sequence similarity with eukaryotic GEFs, it is impossible to predict
the amino acid residues responsible for the different substrate
preferences of SopE and SopE2 from the data of Worthylake et
al. (43).
Do all Salmonella strains address Cdc42 and Rac1?
Phylogenetic analyses have shown that sopE2 is present in
all contemporary Salmonella lineages (21, 22, 26).
Therefore, the capacity to directly activate Cdc42 but not
Rac1 (via SopE2) inside cells of the animal host is common to all
Salmonellae. In contrast, sopE is encoded in the
genome of a bacteriophage, which is only present in very few
Salmonella strains, including the S. typhimurium strain SL1344 used in this study (26, 27, 44, 45). A second S. typhimurium strain (ATCC 14028) that is commonly used to study virulence mechanisms does not carry SopE Nonetheless, expression of SopE improves virulence. Interestingly,
SopE-expressing S. typhimurium strains are associated with severe epidemics (44). It has been speculated that the improved epidemic virulence of these strains might simply be attributable to a
higher "sopE" gene dosage and higher total amounts of
SopE-like proteins delivered into host cells (44). However, the data
presented here suggest that the improved virulence of
sopE-positive S. typhimurium strains is much
rather linked to the capacity of these strains to directly activate
Rac1 and Cdc42 (via SopE) inside host cells.
Indeed, there are several lines of evidence from tissue culture
experiments suggesting that direct activation of Cdc42 and Rac1 are needed to optimize host cell invasion. 1) Disruption of the
sopE gene in S. typhimurium strain SL1344 leads
to a 2-fold decreased invasiveness into COS7 tissue culture cells (27), whereas a sopE2 mutant is equally invasive as the wild-type
SL1344 strain (22). This argues that the presence of SopE can fully compensate for the loss of SopE2, whereas SopE2 (possibly due to its
inability to directly activate Rac1) cannot completely compensate for
the loss of SopE. 2) Complementation of a non-invasive S. typhimurium strain (M516 = SL1344,
sopE Taken together, our results show for the first time that S. typhimurium can specifically activate different RhoGTPases of the
host cell via the translocated effector proteins SopE and SopE2. This
allows the bacteria to fine tune host cellular responses very
precisely. Future work must address how SopE/SopE2-triggered signaling
may be further modulated by the other translocated effector proteins
like the actin-binding protein SipA (19), the phosphatidyl inositol
phosphatase SopB (31), or the GTPase-activating protein SptP
(46). This will further advance our current knowledge of the intricate
network of responses triggered by the translocated effector proteins of
S. typhimurium in order to alter host cell signaling in
a very precise manner.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
RhoGTPase·GTP exchange (5). Only the active
GTP-bound RhoGTPases can interact with downstream elements of signal
transduction cascades mediating the cellular responses. GTPases of the
Rho subfamily are central switches in the signaling cascades regulating
motility, cellular adhesion, cell shape, cytokinesis, cell contraction,
and gene expression (6, 7). Each of the RhoGTPases can regulate a specific set of downstream signaling cascades, leading to activation of
specific cellular functions (4). For example, in Swiss 3T3 cells,
activation of Cdc42 leads to the formation of filopodia, activation of
Rac1 induces formation of lamellipodia, and activation of RhoA leads to
the formation of stress fibers and focal adhesions (8-11). Thus,
selective activation of specific RhoGTPases leads to specific cellular responses.
mutant is less invasive than wild type
S. typhimurium (28, 31). Until now, however, the molecular
mechanism explaining the role of SopB in triggering invasion has been unclear.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
sopB, sopE::aphT,
sopE2::tetr) lacks the three
major effector proteins necessary for tissue culture cell invasion
(26). Transformation of M516 with pM136 (pBAD24, which expresses
SopE1-240-M45 under the control of the native
sopE promotor; Ref. 22) or with pM226 (pBAD24, which
expresses SopE21-240-M45 under the control of the native
sopE2 promotor; Ref. 22) complements the invasion defect. For tissue culture cell infection experiments, the bacteria were grown
in high salt media as described (22).
80 °C.
80 °C.
-Rac1 (1:2500 in PBS, 5% nonfat milk; Upstate
Biotechnology, Inc.) or mouse-
-Cdc42 (1:500, Transduction
Laboratories) antibodies. SopE1-240-M45 and
SopE21-240-M45 proteins were detected using mouse-
M45 antibody (1:100 in PBS, 5% nonfat milk; Ref. 36), a secondary horseradish peroxidase-conjugated
-mouse antibody (1:12000; Dianova) and the ECL Plus detection kit, as recommended by the manufacturer (Amersham Pharmacia Biotech).
-Salmonella O-1,4,5,12(8) antiserum (Difco, 1:400 in PBS, 3% BSA) and a secondary
-rabbit fluorescein isothiocyanate
conjugate (Sigma, 1:250 in PBS, 3% BSA). Coverslips were mounted and
analyzed by fluorescence microscopy. Cells with obvious rearrangments
in the actin cytoskeleton (~35% of all cells) were evaluated and classified based on their cytoskeletal structure.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
) and d (×)). In contrast,
[3H]GDP release from Rac11-191 was much
faster in the presence of SopE78-240 (Fig. 1b,
) than in the presence of 1 µM SopE269-240 (Fig. 1e, ×). Therefore,
SopE78-240 is a highly efficient GEF for
Cdc42Hs1-192 and Rac11-191, whereas
SopE269-240 acts equally efficient on
Cdc42Hs1-192, but is much less active on
Rac11-191 in vitro.

View larger version (25K):
[in a new window]
Fig. 1.
Rates of guanine nucleotide exchange
catalyzed by SopE and SopE2. [3H]GDP release from
Cdc42Hs1-192·[3H]GDP
(panels a and d),
Rac11-191·[3H]GDP
(panels b and e), and
Ha-Ras·[3H]GDP (panels c and
f) in the presence of 1 mM GDP and 1 µM SopE78-240 (
), 1 µM SopE269-240 (×), 10 mM EDTA
(
), or 1 µM GST (
) was analyzed using a filter
binding assay. The data were acquired in three independent
experiments.

View larger version (29K):
[in a new window]
Fig. 2.
Surface plasmon resonance measurement of the
SopE/SopE2 interaction with Cdc42Hs or Rac1. a, binding
kinetics of SopE78-240 (100 nM) and
SopE269-240 (100 nM) to
GST-Cdc42Hs1-192 and GST-Rac11-191.
b, concentration dependence of the rates of binding of
SopE269-240 to GST-Cdc42Hs1-192 or to
GST-Rac11-191. After washing with buffer E (0-90 s), we
applied SopE269-240 in buffer E at the indicated
concentrations. The sensorgrams were corrected to show the specific
signal changes. w, start of washing with buffer E.
Surface plasmon resonance measurement of the association/dissociation
of SopE/SopE2 complexes with GST-Cdc42/GST-Rac1
10
M), whereas equilibrium binding of SopE269-240
to GST-Cdc42Hs1-192 is 40-fold stronger than equilibrium
binding to GST-Rac11-191 (Table I).
C complex (32),
dissociation of all complexes between GST-RhoGTPases and
SopE78-240 or SopE269-240 was accelerated more than 1000-fold in the presence of 20 µM GDP and the
dissociation reactions were completed in less than 5 s (data not
shown). Identical dissociation curves were obtained when we employed 20 µM GTP (data not shown). However, the dissociation
kinetics in the presence of guanine nucleotides were too fast to allow
an accurate analysis in order to detect differences between the
dissociation rates of the complexes with GST-Cdc42Hs1-192
and GST-Rac11-191.
1 and Km = 6 ± 2 µM; Table II) were in the
same order of magnitude as those reported for
SopE78-240-mediated nucleotide exchange on
Cdc42V12·mGDP (kcat = 0.95 ± 0.06 s
1 and Km = 4.5 ± 0.9 µM; Ref. 32). It is unclear whether the slight
differences might be attributable to effects of the G12V mutation of
Cdc42 used in the earlier study (32). SopE269-240 is an
even more efficient GEF for Cdc42Hs1-192 than
SopE78-240 (Table II).

View larger version (15K):
[in a new window]
Fig. 3.
Multiple turnover kinetics of guanine
nucleotide exchange by SopE or SopE2. Release of mGDP from
Rac11-191·mGDP (1-45 µM) or
Cdc42Hs1-192·mGDP (1-60 µM) was analyzed
in the presence of 1 mM GDP and 25 nM
SopE78-240 or SopE269-240 using fluorescence
spectrometry (excitation wavelength = 366 nm; emission
wavelength = 440 nm). The curves were fitted assuming a simple
dissociation mechanism and the resulting rates
(kobs. = [pmol of mGDP released]/[pmol of Sop
protein] × s
1) were plotted as a function of the
concentrations of Rac11-191·mGDP (
) or
Cdc42Hs1-192·mGDP (
).
Multiple turnover measurements of SopE/SopE2-mediated nucleotide
exchange
sopB; Ref.
26), which lacks the three major effector proteins necessary for host cell invasion (26). This strain has a fully functional SPI1 type III
secretion system (26) but it is unable to activate Cdc42- or
Rac1-signaling (see Fig. 4). To analyze
the in vivo specificity of SopE and SopE2, we infected COS7
tissue culture cells for 40 min with the plasmidless control S. typhimurium strain M516 or with M516 complemented with
expression vectors for epitope-tagged SopE1-240-M45 (pM136) or
SopE21-240-M45 (pM226; Ref. 22). COS7 cell lysates were
subsequently analyzed using the GST-PAK-CD affinity precipitation assay
(see "Materials and Methods"). M516 complemented with pM136
(SopE1-240-M45) was able to efficiently activate Cdc42
and Rac1 (Fig. 4, lanes 2a and
2b). In contrast, M516 complemented with pM226
(SopE21-240-M45) only activated Cdc42 but not
Rac1 (Fig. 4, lanes 3a and 3b).
Control experiments verified that the observed differences were not
attributable to different amounts of Rac1 or Sop-proteins present in
the lysates (Fig. 4, lanes 2c, 3c,
1d, 2d, and 3d). In conclusion, these
are in line with the results from the biochemical analyses and show that SopE2 has the capacity to specifically activate Cdc42 signaling in vivo, whereas SopE activates both Rac1 and
Cdc42.

View larger version (36K):
[in a new window]
Fig. 4.
Affinity precipitation assay to measure
activation of host cellular Cdc42 and Rac1 by translocated SopE and
SopE2. COS7 cells were infected for 40 min with M516
(lanes 1a-1d), M516 complemented with pM136
(SopEM45; lanes 2a-2d), or M516
complemented with pM226 (SopE2M45; lanes
3a-3d). Rac1·GTP and Cdc42·GTP present in the COS7
lysates was affinity-precipitated using GST-PAK-CD beads (see
"Materials and Methods"), and quantification of Rac1·GTP and
Cdc42·GTP was performed by Western blot analyses using specific mouse
-Cdc42 (lane a) or mouse
-Rac1
(lane b) antibodies. Lane
c, relative amounts of Sop proteins (or Rac1;
lane d) present in the lysates detected by
Western blot using a specific mouse
-M45 (lane
c) or a mouse
-Rac1 (lane d)
antibody. Lanes 4a-4d, positive control. Rac1
and Cdc42 in lysate were activated by loading with GTP
S.
Lanes 5a-5d, negative control. Rac1 and Cdc42 in
lysate was inactivated by loading with GDP. The assay shown is
representative for the five independent experiments performed.

View larger version (64K):
[in a new window]
Fig. 5.
SopE/SopE2-induced rearrangements in the
HUVEC actin cytoskeleton. a, HUVECs were infected for
40 min with the indicated S. typhimurium strains.
Cells were fixed, f-actin was stained with rhodamine-phalloidin
(red), and bacteria were stained with a polyclonal
-Salmonella antiserum and a secondary
-rabbit
fluorescein isothiocyanate antibody (green; see "Materials
and Methods"). b, quantitative analysis of the
SopE/SopE2-induced cytoskeletal rearrangements. Cells with altered
actin cytoskeletal morphology (~35% of all cells) were classified
based on their morphological features: profound membrane ruffling
(i.e. a, panel 2), weak
filopodia formation (<20 filopodia/cell), pronounced filopodia
formation (>20 filopodia/cell; i.e. a,
panel 3). For each S. typhimurium
strain, at least 100 cells with altered actin cytoskeletal morphology
were evaluated in three independent experiments (experimental error:
±10%). *, no cytoskeletal rearrangements observed.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
and does not express SopE.2 Therefore, the
capacity to directly activate Rac1 signaling (via SopE) is not strictly
required for Salmonella virulence per se. However, it is certainly possible that SopE2 can activate Rac1 via an
indirect mechanism, as it is known that specific activation of Cdc42
will finally result in activation Rac1 in Swiss 3T3 fibroblasts (11).
, sopE2
,
sopB
), which lacks all three translocated
effector proteins triggering bacterial entry with a SopE expression
vector, is 2-fold more efficient than complementation with a SopE2
expression vector (26). 3) Disruption of Cdc42 signaling inside COS7
cells by transfection with Cdc42N17 expression vectors is
2-fold more efficient at blocking S. typhimurium SL1344
invasion than disruption of Rac1 signaling via Rac1N17
(23). In conclusion, these observations suggest that the capacity to
directly activate Rac1 (in addition to Cdc42) via SopE improves
S. typhimurium virulence.
| |
ACKNOWLEDGEMENT |
|---|
We thank Dr. Irmgard Assfalg-Machleidt for helpful instructions for performance and evaluation of surface plasmon resonance measurements on the BIAcore 2000 instrument.
| |
FOOTNOTES |
|---|
* This work was supported by grants from the Deutsche Forschungsgemeinschaft (Nachwuchsgruppe of W.-D. Hardt; BIAcore 2000-work Sonderforschungsbereich 469 of the Ludwig Maximilians Universität München, Grant A-6/Machleidt).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel.: 49-89-5160-5263; Fax: 49-89-5160-5223; E-mail: hardt@m3401.mpk.med.uni-muenchen.de.
Published, JBC Papers in Press, July 5, 2001, DOI 10.1074/jbc.M100609200
2 S. Mirold and W.-D. Hardt, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: GEF, guanine nucleotide exchange factor; aa, amino acid(s); mGDP, O-(N-methylanthraniloyl)-GDP; GST, glutathione S-transferase; HUVEC, human umbilical vein endothelial cell; CD, Cdc42/Rac1-binding domain; PH, pleckstrin homology; DH, Dbl homology; PAK, p21-activated kinase; DTT, dithiothreitol; PBS, phosphate-buffered saline; BSA, bovine serum albumin; SPI1, Salmonella pathogenicity island I.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ridley, A. J. (2000) in GTPases (Hall, A., ed) , pp. 89-136, Oxford University Press, Oxford |
| 2. | Bourne, H. R., Sanders, D. A., and McCormick, F. (1991) Nature 349, 117-127 |
| 3. | Boguski, M. S., and McCormick, F. (1993) Nature 366, 643-654 |
| 4. | Bishop, A. L., and Hall, A. (2000) Biochem. J. 348, 241-255 |
| 5. | Cerione, R. A., and Zheng, Y. (1996) Curr. Opin. Cell Biol. 8, 216-222 |
| 6. | Hall, A. (1998) Science 279, 509-514 |
| 7. | Van Aelst, L., and D'Souza-Schorey, C. (1997) Genes Dev. 11, 2295-2322 |
| 8. | Ridley, A. J., and Hall, A. (1992) Cell 70, 389-399 |
| 9. | Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., and Hall, A. (1992) Cell 70, 401-410 |
| 10. | Kozma, R., Ahmed, S., Best, A., and Lim, L. (1995) Mol. Cell. Biol. 15, 1942-1952 |
| 11. | Nobes, C. D., and Hall, A. (1995) Cell 81, 53-62 |
| 12. | Galán, J. E. (1999) Curr. Opin. Microbiol. 2, 46-50 |
| 13. | Wood, M. W., Rosqvist, R., Mullan, P. B., Edwards, M. H., and Galyov, E. E. (1996) Mol. Microbiol. 22, 327-338 |
| 14. | Galyov, E. E., Wood, M. W., Rosqvist, R., Mullan, P. B., Watson, P. R., Hedges, S., and Wallis, T. S. (1997) Mol. Microbiol. 25, 903-912 |
| 15. | Collazo, C. M., and Galán, J. E. (1997) Mol. Microbiol. 24, 747-756 |
| 16. | Hardt, W.-D., and Galán, J. E. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 9887-9892 |
| 17. | Jones, M. A., Wood, M. W., Mullan, P. B., Watson, R., Wallis, T. J., and Galyov, E. E. (1998) Infect. Immun. 66, 5799-5804 |
| 18. | Fu, Y., and Galán, J. E. (1998) Mol. Microbiol. 27, 359-368 |
| 19. | Zhou, D., Mooseker, M. S., and Galán, J. E. (1999) Science 283, 2092-2095 |
| 20. | Miao, E. A., Scherer, C. A., Tsolis, R. M., Kingsley, R. A., Adams, L. G., Bäumler, A. J., and Miller, S. I. (1999) Mol. Microbiol. 34, 850-864 |
| 21. | Bakshi, C. S., Singh, V. P., Wood, M. W., Jones, P. W., Wallis, T. S., and Galyov, E. E. (2000) J. Bacteriol. 182, 2341-2344 |
| 22. | Stender, S., Friebel, A., Linder, S., Rohde, M., Mirold, S., and Hardt, W.-D. (2000) Mol. Microbiol. 36, 1206-1221 |
| 23. | Chen, L. M., Hobie, S., and Galán, J. E. (1996) Science 274, 2115-2118 |
| 24. | Hardt, W.-D., Chen, L. M., Schuebel, K. E., Bustelo, X. R., and Galán, J. E. (1998) Cell 93, 815-826 |
| 25. | Chen, L. M., Bagrodia, S., Cerione, R. A., and Galán, J. E. (1999) J. Exp. Med. 189, 1479-1488 |
| 26. | Mirold, S., Ehrbar, K., Weissmüller, A., Prager, R., Tschäpe, H., Rüssmann, H., and Hardt, W.-D. (2001) J. Bacteriol. 183, 2348-2358 |
| 27. | Hardt, W.-D., Urlaub, H., and Galán, J E. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 2574-2579 |
| 28. | Hong, K. H., and Miller, V. L. (1998) J. Bacteriol. 180, 1793-1802 |
| 29. | Galán, J. E., and Zhou, D. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 8754-8761 |
| 30. | Zhou, D., Chen, L. M., Hernandez, L., Shears, S. B., and Galán, J. E. (2001) Mol. Microbiol. 39, 248-259 |
| 31. | Norris, F. A., Wilson, M. P., Wallis, T. S., Galyov, E. E., and Majerus, P. W. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 14057-14059 |
| 32. | Rudolph, M. G., Weise, C., Mirold, S., Hillenbrand, B., Bader, B., Wittinghofer, A., and Hardt, W.-D. (1999) J. Biol. Chem. 274, 30501-30509 |
| 33. | Hoiseth, S. K., and Stocker, B. A. (1981) Nature 291, 238-239 |
| 34. | Friebel, A., and Hardt, W. D. (2000) Methods Enzymol. 325, 82-91 |
| 35. | Sander, E. E., van Delft, S., ten Klooster, J. P., Reid, T., van der Kammen, R. A., Michiels, F., and Collard, J. G. (1998) J. Cell Biol. 143, 1385-1398 |
| 36. | Obert, S., O'Connor, R. J., Schmid, S., and Hearing, P. (1994) Mol. Cell. Biol. 2, 1333-1346 |
| 37. | Aepfelbacher, M., Essler, M., Huber, E., Sugai, M., and Weber, P. C. (1997) Arterioscler. Thromb. Vasc. Biol. 17, 1623-1629 |
| 38. | Leonard, D. A., Evans, T., Hart, M., Cerione, R. A., and Manor, D. (1994) Biochemistry 33, 12323-12328 |
| 39. | Rudolph, M. G., Bayer, P., Abo, A., Kuhlmann, J., Vetter, I. R., and Wittinghofer, A. (1998) J. Biol. Chem. 273, 18067-18076 |
| 40. | Azim, A. C., Barkalow, K. L., and Hartwig, J. H. (2000) Methods Enzymol. 325, 257-263 |
| 41. | Andor, A., Trülzsch, K., Essler, M., Roggenkamp, A., Wiedemann, A., Heesemann, J., and Aepfelbacher, M. (2001) Cell. Microbiol. 3, 301-310 |
| 42. | Stam, J. C., and Collard, J. G. (1999) Prog. Mol. Subcell. Biol. 22, 51-83 |
| 43. | Worthylake, D. K., Rossman, K. L., and Sondek, J. (2000) Nature 408, 682-688 |
| 44. | Mirold, S., Rabsch, W., Rohde, M., Stender, S., Tschäpe, H., Rüssmann, H., Igwe, E., and Hardt, W.-D. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 9845-9850 |
| 45. | Prager, R., Mirold, S., Tietze, E., Strutz, U., Knüppel, B., Rabsch, W., Hardt, W.-D., and Tschäpe, H. (2000) Int. J. Med. Microbiol. 290, 605-617 |
| 46. | Fu, Y., and Galán, J. E. (1999) Nature 401, 293-297 |
This article has been cited by other articles:
![]() |
K. R. Buchholz and R. S. Stephens The Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Induces the Inflammatory Factor Interleukin-8 following Chlamydia trachomatis Infection Infect. Immun., December 1, 2007; 75(12): 5924 - 5929. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Brown, L. Bry, Z. Li, and D. B. Sacks IQGAP1 Regulates Salmonella Invasion through Interactions with Actin, Rac1, and Cdc42 J. Biol. Chem., October 12, 2007; 282(41): 30265 - 30272. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Boyle, N. F. Brown, J. H. Brumell, and B. B. Finlay Src homology domain 2 adaptors affect adherence of Salmonella enterica serovar Typhimurium to non-phagocytic cells Microbiology, October 1, 2007; 153(10): 3517 - 3526. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. V. Thijs, S. C. J. De Keersmaecker, A. Fadda, K. Engelen, H. Zhao, M. McClelland, K. Marchal, and J. Vanderleyden Delineation of the Salmonella enterica Serovar Typhimurium HilA Regulon through Genome-Wide Location and Transcript Analysis J. Bacteriol., July 1, 2007; 189(13): 4587 - 4596. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Patel and J. E. Galan Differential activation and function of Rho GTPases during Salmonella-host cell interactions J. Cell Biol., November 6, 2006; 175(3): 453 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Brown, J. Szeto, X. Jiang, B. K. Coombes, B. B. Finlay, and J. H. Brumell Mutational analysis of Salmonella translocated effector members SifA and SopD2 reveals domains implicated in translocation, subcellular localization and function. Microbiology, August 1, 2006; 152(Pt 8): 2323 - 2343. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Jiang and S. Ramachandran Comparative and evolutionary analysis of genes encoding small GTPases and their activating proteins in eukaryotic genomes Physiol Genomics, February 23, 2006; 24(3): 235 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Balana, F. Niedergang, A. Subtil, A. Alcover, P. Chavrier, and A. Dautry-Varsat ARF6 GTPase controls bacterial invasion by actin remodelling J. Cell Sci., May 15, 2005; 118(10): 2201 - 2210. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Panthel, K. M. Meinel, V. E. S. Domenech, H. Retzbach, E. I. Igwe, W.-D. Hardt, and H. Russmann Salmonella Pathogenicity Island 2-Mediated Overexpression of Chimeric SspH2 Proteins for Simultaneous Induction of Antigen-Specific CD4 and CD8 T Cells Infect. Immun., January 1, 2005; 73(1): 334 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-C. Huang, A. Werne, Q. Li, E. E. Galyov, W. A. Walker, and B. J. Cherayil Cooperative Interactions between Flagellin and SopE2 in the Epithelial Interleukin-8 Response to Salmonella enterica Serovar Typhimurium Infection Infect. Immun., September 1, 2004; 72(9): 5052 - 5062. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Drecktrah, L. A. Knodler, and O. Steele-Mortimer Modulation and Utilization of Host Cell Phosphoinositides by Salmonella spp. Infect. Immun., August 1, 2004; 72(8): 4331 - 4335. [Full Text] [PDF] |
||||
![]() |
S. M. Bueno, C. A. Santiviago, A. A. Murillo, J. A. Fuentes, A. N. Trombert, P. I. Rodas, P. Youderian, and G. C. Mora Precise Excision of the Large Pathogenicity Island, SPI7, in Salmonella enterica Serovar Typhi J. Bacteriol., May 15, 2004; 186(10): 3202 - 3213. [Abstract] [Full Text] [PDF] |
||||